| Entry |
|
|---|
| Name |
Betacetylmethadol (INN) |
|---|
| Formula |
C23H31NO2
|
|---|
| Exact mass |
353.2355
|
|---|
| Mol weight |
353.50
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
Analgesic
DG01984 Opioid analgesics
|
|---|
| Efficacy |
Analgesic (narcotic), Opioid receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
D12661 Betacetylmethadol
Analgesic
DG01984 Opioid analgesics
D12661 Betacetylmethadol
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRM1
D12661 Betacetylmethadol (INN)
Narcotics and psychotropics in Japan [br08308.html]
Narcotics by Control Act Article 2 Table 1 (76 substances)
D12661
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 26
1 C8x C 15.5066 -17.6114
2 C8x C 15.5066 -18.9445
3 C8x C 16.6994 -19.6462
4 C8x C 17.8922 -18.9445
5 C8y C 17.8922 -17.6114
6 C8x C 16.6994 -16.9097
7 C8x C 20.2778 -18.9445
8 C8y C 20.2778 -17.6114
9 C1d C 19.0850 -16.9097
10 C8x C 21.4005 -19.6462
11 C8x C 22.5933 -18.9445
12 C8x C 22.5933 -17.6114
13 C8x C 21.4005 -16.9097
14 C1b C 19.0850 -15.5064
15 C1c C 20.2778 -14.8750
16 C1c C 17.0502 -15.7871
17 C1a C 21.4005 -15.5064
18 C1b C 15.8574 -16.4887
19 C1a C 14.7348 -15.7871
20 O7a O 17.0502 -14.4540
21 C7a C 15.8574 -13.7523
22 C1a C 14.6646 -14.4540
23 O6a O 15.8574 -12.3490
24 N1c N 20.2778 -13.4717
25 C1a C 21.4005 -12.7700
26 C1a C 19.0149 -12.7700
BOND 27
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 8 1
8 8 9 1
9 5 9 1
10 7 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 8 13 2
15 9 14 1
16 14 15 1
17 9 16 1
18 15 17 1
19 16 18 1
20 18 19 1
21 20 21 1
22 21 22 1
23 21 23 2
24 16 20 1 #Down
25 24 25 1
26 24 26 1
27 15 24 1 #Down
|
|---|
